Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,648.37 -1,063.69 (-1.72%) CMC Crypto 200
1,264.69 -19.14 (-1.49%)
INVA Sep 2024 15.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:26PM EDT
| Previous close | 2.0500 |
| Open | 2.0000 |
| Bid | 1.6500 |
| Ask | 3.0000 |
| Strike | 15.00 |
| Expiry date | 2024-09-20 |
| Day's range | 2.0000 - 2.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 312 |
Simply Wall St.Calculating The Fair Value Of Innoviva, Inc. (NASDAQ:INVA)
Key Insights Innoviva's estimated fair value is US$19.59 based on 2 Stage Free Cash Flow to Equity Current share price...
Business WireInnoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
BURLINGAME, Calif., June 03, 2024--Innoviva, Inc. (Nasdaq: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL
- GuruFocus.com
Innoviva Inc (INVA) Reports First Quarter 2024 Earnings: A Detailed Analysis
Strong Performance with Significant Growth in Net Product Revenue
© 2024 Yahoo. All rights reserved.